InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Universe Pharmaceuticals INC

UPC Clue Score43
China Fiscal year ends September CIK 0001809616
$4.15 -0.72% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.15 +75.85% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 23 Mar 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue0.03Operating income0.01Net income0.01Fiscal year 2020Revenue0.03 −7.6%Operating income0.01Net income0.01 +0.1%EPS, diluted0.47Fiscal year 2021Revenue0.05 +56.3%Operating income0.01Net income0.01 +49.8%EPS, diluted3.58Fiscal year 2022Revenue0.04 −16.3%Operating income−0.01Net income−0.01 −169.9%EPS, diluted−1,309.11Fiscal year 2023Revenue32.31 +80,383.8%Operating income−3.97Net income−6.58EPS, diluted−1,089.21Fiscal year 2024Revenue23.02 −28.7%Operating income−8.02Net income−8.73EPS, diluted−626.96Fiscal year 2025Revenue17.86 −22.4%Operating income−2.92Net income−3.67EPS, diluted−8.06
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.03 0.03 0.05 0.04 32.31 23.02 17.86
Growth −7.6% +56.3% −16.3% +80,383.8% −28.7% −22.4%
Operating income 0.01 0.01 0.01 −0.01 −3.97 −8.02 −2.92
Net income 0.01 0.01 0.01 −0.01 −6.58 −8.73 −3.67
Growth +0.1% +49.8% −169.9%
EPS, diluted n/a 0.47 3.58 −1,309.11 −1,089.21 −626.96 −8.06

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Gross margin40.3%Operating margin29.4%Net margin22.7%Free cash flow margin39.5%Fiscal year 2020Gross margin45.9%Operating margin33.4%Net margin24.6%Free cash flow margin19.7%Fiscal year 2021Gross margin52.8%Operating margin28.3%Net margin23.6%Free cash flow margin−5.2%Fiscal year 2022Gross margin54.5%Operating margin−17.5%Net margin−19.7%Free cash flow margin−3.5%Fiscal year 2023Gross margin31.9%Operating margin−12.3%Net margin−20.4%Free cash flow margin3.3%Fiscal year 2024Gross margin26.4%Operating margin−34.8%Net margin−37.9%Free cash flow margin−42.2%Fiscal year 2025Gross margin35.3%Operating margin−16.3%Net margin−20.6%Free cash flow margin−29.8%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 40.3% 45.9% 52.8% 54.5% 31.9% 26.4% 35.3%
Operating margin 29.4% 33.4% 28.3% −17.5% −12.3% −34.8% −16.3%
Net margin 22.7% 24.6% 23.6% −19.7% −20.4% −37.9% −20.6%
Free cash flow margin 39.5% 19.7% −5.2% −3.5% 3.3% −42.2% −29.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow0.01Capital expenditure−0.00Free cash flow0.01Dividends paid−0.02Fiscal year 2020Operating cash flow0.01Capital expenditure−0.00Free cash flow0.01 −53.8%Fiscal year 2021Operating cash flow−0.00Capital expenditure−0.00Free cash flow−0.00 −141.2%Fiscal year 2022Operating cash flow−0.00Capital expenditure−0.00Free cash flow−0.00Fiscal year 2023Operating cash flow1.12Capital expenditure−0.04Free cash flow1.07Fiscal year 2024Operating cash flow−9.51Capital expenditure−0.21Free cash flow−9.72 −1,005.7%Fiscal year 2025Operating cash flow−5.05Capital expenditure−0.27Free cash flow−5.32
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 0.01 0.01 −0.00 −0.00 1.12 −9.51 −5.05
Capital expenditure −0.00 −0.00 −0.00 −0.00 −0.04 −0.21 −0.27
Free cash flow 0.01 0.01 −0.00 −0.00 1.07 −9.72 −5.32
Growth −53.8% −141.2% −1,005.7%
Dividends paid −0.02 n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash0.00Shareholders’ equity0.01Fiscal year 2020Cash0.01Shareholders’ equity0.02Fiscal year 2021Cash0.01Shareholders’ equity0.05Fiscal year 2022Cash5.71Shareholders’ equity35.33Fiscal year 2023Cash5.29Shareholders’ equity27.97Fiscal year 2024Cash29.50Shareholders’ equity45.50Fiscal year 2025Cash33.59Total debt2.11Net cash (debt)31.48Shareholders’ equity56.13Debt to equity0.04
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.00 0.01 0.01 5.71 5.29 29.50 33.59
Total debt n/a n/a n/a n/a n/a n/a 2.11
Net cash (debt) n/a n/a n/a n/a n/a n/a 31.48
Shareholders’ equity 0.01 0.02 0.05 35.33 27.97 45.50 56.13
Debt to equity n/a n/a n/a n/a n/a n/a 0.04

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending September, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 30 Sep 2019 FY2020 30 Sep 2020 FY2021† 30 Sep 2021 FY2022† 30 Sep 2022 FY2023 30 Sep 2023 FY2024† 30 Sep 2024 FY2025† 30 Sep 2025
Revenue and profit
0.03 0.03 0.05 0.04 32.31 23.02 17.86
Growth −7.6% +56.3% −16.3% +80,383.8% −28.7% −22.4%
0.02 0.02 0.02 0.02 21.99 16.95 11.56
0.01 0.01 0.03 0.02 10.32 6.07 6.30
Growth +5.1% +79.7% −13.6% +47,019.7% −41.1% +3.8%
0.00 0.00 0.01 0.01 4.86 3.03 0.67
0.00 0.00 0.00 0.00 2.64 2.89 3.75
0.01 0.01 0.01 −0.01 −3.97 −8.02 −2.92
Growth +5.1% +32.6% −151.7%
0.01 0.01 0.01 −0.01 −4.33 −8.12 −3.67
0.00 0.00 0.00 0.00 2.25 0.61 n/a
0.01 0.01 0.01 −0.01 −6.58 −8.73 −3.67
Growth +0.1% +49.8% −169.9%
Per share
n/a 0.47 3.58 −1,309.11 −1,089.21 −626.96 −8.06
n/a 0.47 3.58 −1,309.11 −1,089.21 −626.96 −8.06
Growth +661.7% −36,667.3%
n/a 16.0 3.2 0.0 0.0 0.0 0.5
n/a 16.0 3.2 0.0 0.0 0.0 0.5
Growth −80.2% −99.8% +0.0% +130.4% +3,174.9%

† The diluted share count jumps at 2021 and 2022 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 257.2% a year over five years.
  • Operating margin is down 49.7 points on five years ago, at -16.3%.
  • A net loss in 4 of 7 years on file.